Recap of "Mad Money" - 1/22/09
Ockham's daily Recap of Mad Money.
Listed below are stocks that were mentioned in CNBC's Mad Money on Thursday January, 22nd.
Jim Cramer CNBC’s biggest star, hosts Mad Money each night of the week at 6pm ET. The hour long show is both entertaining and informative and each stock mentioned receives a lot of attention simply by virtue of being mentioned on Mad Money. Popular portions of Mad Money include Mad Mail, Am I Diversified and Lightning Round where Jim Cramer takes callers questions on air.
Want to know everything that was said on Mad Money? Then you have to watch it. Visit CNBC for show times and channel guides.
CNBC - Mad Money Stock Commentary for 1/22/2009
|
6:57P, Jan. 22,2009
GOOG
$306.50 Google, Inc.
Google, Incorporated (GOOG) Discussed on CNBC's Mad Money Google, Incorporated is in the news. Find out how this impacts GOOG trading on Ockham Research. >>> good numbers from GOOGLE matter. That's how depressing and horrible the bank stocks they keep reporting. I like to say there is always a I try to find it swruts for you right here on "mad money." “… >>> good numbers from GOOGLE matter. That's how depressing and horrible the bank stocks they keep reporting. I like to say there is always a I try to find it swruts for you right here on "mad money." …” |
|
6:50P, Jan. 22,2009
GOOG
$306.50 Google, Inc.
Google, Incorporated (GOOG) Discussed on CNBC's Mad Money Google, Incorporated is in the news. Find out how this impacts GOOG trading on Ockham Research. Think it's going happen. >> I don't want to lump you in for a company that reported a bad number today, microsoft, but you have a lot of products that can be cross-plat form. Talk about your iphone and GOOGLE issues. >> the iphone is a great we'll introduce it it at the upcoming hims and it's already out in the field testing. It makes it easy for physicians any time, anywhere makes it easy forfy “… ce it it at the upcoming hims and it's already out in the field testing. It makes it easy for physicians any time, anywhere makes it easy forfy …” |
|
6:50P, Jan. 22,2009
MSFT
$17.11 Microsoft Corp.
Microsoft Corporation (MSFT) Discussed on CNBC's Mad Money Microsoft Corporation is in the news. Find out how this impacts MSFT trading on Ockham Research. Direct funding and long-term incentives for physician to use electronic health records and we're excited about it and we think it's going happen. >> I don't want to lump you in for a company that reported a bad number today, MICROSOFT, but you have a lot of products that can be cross-plat form. Talk about your iphone and google issues. >> the iphone is a great we'll introduce it it at the “… of products that can be cross-plat form. Talk about your iphone and google issues. >> the iphone is a great we'll introduce it it at the …” |
|
6:44P, Jan. 22,2009
S
$2.38 Sprint Nextel Corp.
Sprint Nextel Corporation (S) Discussed on CNBC's Mad Money Sprint Nextel Corporation is in the news. Find out how this impacts S trading on Ockham Research. Because you know what? I am a benevolent king. >> let's any to pedro in >> boo-yah, mr. Cramer. What do you think of s stock from SPRINT NEXTEL. Sprint is too speck lat you have for me. Sprint and qwest are too speculative. Why are they speculative? There's a good answer? They're interesting good takeover plays and I never “… 's a good answer? They're interesting good takeover plays and I never …” |
|
6:43P, Jan. 22,2009
ABCO
$19.03 The Advisory Board Company
The Advisory Board Company (ABCO) Discussed on CNBC's Mad Money The Advisory Board Company is in the news. Find out how this impacts ABCO trading on Ockham Research. >> jim I want to give you a nation's capitol, i'm glad the inawing raises are over boo-yah. >> excellent day after boo-yah. >> I want to ask you about ABCO, THE ADVISORY BOARD company, what am I buying? >> I don't know. I don't know THE ADVISORY BOARD. Like del monte which will drill down, I will get a rundown on THE ADVISORY BOARD. I do not know it. I I know I don't know it because it's an attractive industry, but i'm sorry that I have to punt on “… ke del monte which will drill down, I will get a rundown on THE ADVISORY BOARD. I do not know it. I I know I don't know it because it's an attractive industry, but i'm sorry that I have to punt on …” |
|
6:43P, Jan. 22,2009
DEL
$41.10 Deltic Timber Corp.
Deltic Timber Corporation (DEL) Discussed on CNBC's Mad Money Deltic Timber Corporation is in the news. Find out how this impacts DEL trading on Ockham Research. >> I want to ask you about abco, the advisory board company, what am I buying? >> I don't know. I don't know the advisory board. Like del monte which will drill down, I will get a rundown on the advisory board. I do not know it. I I know I don't know it because it's an attractive industry, but “… ecause it's an attractive industry, but …” |
|
6:43P, Jan. 22,2009
APC
$36.09 Anadarko Petroleum Corp.
Anadarko Petroleum Corporation (APC) Discussed on CNBC's Mad Money Anadarko Petroleum Corporation is in the news. Find out how this impacts APC trading on Ockham Research. Reduce your take and I was wonder what your take on that >> we had bob simpson on reese we wanted to ask him about it and it was for diversification, it is the second best run and the natural gas company after ANADARKO, i'm not recommend anything natural gas companies and i'm only recommending a natural gas transmission company with the kinder morgan partners. There's too much downside to the natural gas because there's too much downside to natural gas, “… gas companies and i'm only recommending a natural gas transmission company with the kinder morgan partners. There's too much downside to the natural gas because there's too much downside to natural gas, …” |
|
6:42P, Jan. 22,2009
XTO
$34.42 XTO Energy, Inc.
XTO Energy, Incorporated (XTO) Discussed on CNBC's Mad Money XTO Energy, Incorporated is in the news. Find out how this impacts XTO trading on Ockham Research. >> renee. Hi, jim, boo-yah from rhode >> holy cow, good to have you, >> i'm a young investor and I own natural gas stock XTO ENERGY, xto, they're working to reduce your take and I was wonder what your take on that >> we had bob simpson on reese we wanted to ask him about it and it was for diversification, it is the second best run and “… to ask him about it and it was for diversification, it is the second best run and …” |
|
6:41P, Jan. 22,2009
OMG
$18.42 OM Group, Inc.
OM Group, Inc. (OMG) Discussed on CNBC's Mad Money OM Group, Inc. is in the news. Find out how this impacts OMG trading on Ockham Research. I was going to be in ohio right >> you are? >> oh, well -- figuratively. Hey, during green week in 2007 you recommended OM group, symbol o america g. >> when it hit 58 in april of '08 you suggested to sell. Good call. >> I like omg's leadership, green seems to be back and with oil prices eventually increasing is it time to ride this one back up. >> this is an oil mineral company and I cannot recommend the mineral company until I see “… ms to be back and with oil prices eventually increasing is it time to ride this one back up. >> this is an oil mineral company and I cannot recommend the mineral company until I see …” |
|
6:41P, Jan. 22,2009
IMA
$24.22 Inverness Medical Innovations, Inc.
Inverness Medical Innovations, Incorporated (IMA) Discussed on CNBC's Mad Money Inverness Medical Innovations, Incorporated is in the news. Find out how this impacts IMA trading on Ockham Research. >> holy cow! Let's get to -- no, we have to take the stock question. What's up? >> can I get your opinion on optimism ima pharmaceuticals? >> incredibly interesting speck. I absolutely would tell you that if you put that stock as a biotech spec play as we do when “… do when …” |

